Pricing Log in Create free account
Wednesday 14 October 2026 Export OSCR’s income statement to Excel — free account

Oscar Health, Inc.

OSCR Healthcare Healthcare Plans

Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024. In the quarter to June 2026, revenue grew 70.4%, EPS grew 234.8%, free cash flow grew 316.3% and total debt rose 43.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

33.79 0.22 −0.65%
Market cap
$10.5B
P/E
19.8×
Fwd P/E
29.7×
Dividend yield
—
F-score
3/9
Altman Z
1.07
Beneish M
−2.18
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 11.92
Total sells 150.02
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — 1 — — — — — —
Sell 1 6 3 — 5 — 2 8 1 2 6 —
Insider Ownership 16.39%

Capital & Financial Ratios $m

Market Cap 10,500.00
Revenue 15,318.63
Net Income 550.93
Free Cash Flow 4,379.95
Net Debt (3,643.98)
Current Ratio 0.57 (below 1: weak)
Debt/Equity 0.21 (at or below 0.5: strong)
P/E ratio 19.76
Fwd P/E 29.70
P/S ratio 0.67
P/B ratio 4.97
Past 5Y EPS Growth —
This Y EPS Growth 214.41% (at or above 15%: strong)
Next Y EPS Growth 23.44% (at or above 15%: strong)
Next Y revenue growth 60.08% (at or above 10%: strong)
Next 5Y EPS Growth 114.55% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.4×, against a ten-year median of 0.2×; over the ten years it ranged from −0.4× in 2022 to 2.5× in 2021.
P/S against its own 10 years 77.39%
10-year low 10-year high
P/B against its own 10 years 97.63%
10-year low 10-year high
EV/Sales against its own 10 years 82.03%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 1,870 1,527 2,774 4,076
Receivables 253 381 499 757
Inventory — — — —
Other — — — —
2,124 1,908 3,273 4,833
2023 2024 2025 Q'26
Payables 2,363 3,389 4,696 8,522
ST’ Debt — — — —
Other — — — —
2,363 3,389 4,696 8,522

Compound Annual Growth %

10y 5y 3y
Sales — 90.80% 43.45%
Cash Flow — 37.50% 42.25%
Earnings — 0.00% 0.00%
Book Value — 16.91% 3.20%

Revenue $m

Mar Jun Sep Dec Year
’26 4,647 4,880 — — —
’25 3,046 2,864 2,986 2,805 11,701
’24 2,142 2,219 2,423 2,392 9,178
’23 1,470 1,522 1,440 1,432 5,863
’22 973 1,017 978 995 3,964
’21 369 529 444 496 1,839
’20 88 115 102 158 463
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 2,619 2,092 — — —
’25 879 509 (965) 672 1,095
’24 634 497 (500) 347 978
’23 415 166 (1,149) 297 (272)
’22 563 214 (548) 151 380
’21 318 55 (589) 34 (182)
’20 106 246 (219) 89 223
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 2,610 2,081 — — —
’25 870 500 (974) 663 1,058
’24 628 490 (508) 340 950
’23 407 160 (1,156) 291 (298)
’22 557 208 (558) 144 351
’21 311 49 (595) 27 (208)
’20 102 242 (222) 86 209
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 2.07 1.10 — — —
’25 0.92 (0.89) (0.53) (1.24) (1.69)
’24 0.62 0.20 (0.22) (0.62) 0.10
’23 (0.18) (0.07) (0.29) (0.66) (1.22)
’22 (0.36) (0.53) (0.91) (1.05) (2.85)
’21 (0.98) (0.35) (1.02) (0.95) (3.20)
’20 (3.36) (1.42) (2.72) (6.41) (13.90)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.5
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — 7.51 2.05 2.39 8.44 11.20

Analyst estimates 2026–2028

Powerpack
High — — — — — 37.00 10.53 9.89 23.79 23.80
People
People Employees — — — — 1,839 2,621 2,714 2,400 2,400 2,305
Revenue/emp, $m — — — 0.00 0.25 0.70 1.46 2.44 3.82 5.08
Income, $m
Income, $m Revenue — — — 488 463 1,839 3,964 5,863 9,178 11,701
Gross margin, % — — — 16.37 33.16 11.68 17.23 20.82 20.10 14.38
EBT — — — (259) (406) (571) (610) (267) 33 (437)
EBT margin, % — — — (53.13) (87.68) (31.03) (15.39) (4.56) 0.36 (3.74)
Net income — — — (261) (407) (571) (610) (271) 26 (443)
Depreciation — — — 0 14 23 18 2 6 1
Per share, $
Per share, $ Revenue — — — 16.94 15.82 10.27 18.65 26.45 38.18 44.60
Earnings — — — (9.06) (13.90) (3.20) (2.85) (1.22) 0.11 (1.69)
Cash flow — — — (5.74) 7.61 (1.02) 1.79 (1.23) 4.07 4.17
Capex — — — (0.90) (0.48) (0.14) (0.14) (0.12) (0.12) (0.14)
Free cash flow — — — (6.64) 7.13 (1.16) 1.65 (1.34) 3.95 4.03
Book value — — — 12.17 15.34 7.78 4.20 3.64 4.23 3.74
Shares, m — — — 29 29 179 212 222 240 262
Valuation, ×
Valuation, × P/E — — — 0.00 0.00 0.00 0.00 0.00 79.06 0.00
P/S — — — 2.20 2.20 0.76 0.13 0.34 0.35 0.32
P/B — — — 0.00 0.00 1.01 0.59 2.50 3.18 3.84
EV/Sales — — — 0.72 0.72 0.24 (0.19) 0.08 0.22 0.12
EV/FCF — — — 1.60 1.60 (2.14) (2.10) (1.50) 2.11 1.35
Cash, $m
Cash, $m Operating cash flow — — — (165) 223 (182) 380 (272) 978 1,095
Capex — — — (26) (14) (26) (29) (26) (28) (36)
Free cash flow — — — (191) 209 (208) 351 (298) 950 1,058
Balance, $m
Balance, $m Working capital — — — (570) (671) (494) (1,360) (240) (1,481) (1,424)
Total debt — — — — 142 — 298 299 300 430
Net debt — — — (337) (684) (1,104) (1,261) (1,572) (1,228) (2,344)
Shareholders’ equity — — — 351 449 1,393 892 806 1,016 981
Returns, %
Returns, % ROA — — — (20.62) (22.89) (20.47) (15.45) (6.66) 0.60 (7.94)
ROIC — — — (1,161.14) 0.00 (117.94) 0.00 0.00 0.00 0.00
ROE — — — 23.31 36.97 (1,185.16) (53.07) (31.88) 2.79 (44.38)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Oscar Health, Inc. vs peers in Healthcare Plans (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ELV Elevance Health, Inc. $91.5B 18.8× 20.3× +1.40% (above 0%: growing) −13.08% (below 0%: shrinking) −9.01% (below 0%: shrinking) 15.77% 4.56% Compare
CI Cigna Group $74.9B 11.7× 11.4× +6.68% (above 0%: growing) +10.16% (above 0%: growing) +66.93% (above 0%: growing) 88.24% 3.73% Compare
HUM Humana Inc. $52.1B 39.5× 42.9× +26.18% (above 0%: growing) +27.88% (above 0%: growing) +58.51% (above 0%: growing) 13.45% 3.33% Compare
CNC Centene Corporation $33.1B — (loss-making) 24.8× +9.92% (above 0%: growing) n/m +116.61% (above 0%: growing) 8.59% 2.24% Compare
MOH Molina Healthcare, Inc $10.7B — (loss-making) 55.0× −4.84% (below 0%: shrinking) −74.95% (below 0%: shrinking) +5.81% (above 0%: growing) 13.19% 1.33% Compare
OSCR Oscar Health, Inc. $10.5B 19.8× 29.7× +70.40% (above 0%: growing) n/m +316.29% (above 0%: growing) 22.25% 7.96%
CLOV Clover Health Investments, Corp. $2.5B — (loss-making) 292× +55.60% (above 0%: growing) n/m +406.43% (above 0%: growing) 20.59% 3.77% Compare
PGNY Progyny, Inc. $2.2B 28.2× 19.9× +5.30% (above 0%: growing) +80.00% (above 0%: growing) −12.01% (below 0%: shrinking) 25.48% 11.41% Compare
ALHC Alignment Healthcare, Inc. $1.7B 39.5× 80.3× +31.55% (above 0%: growing) +125.00% (above 0%: growing) −229.51% (below 0%: shrinking) 13.55% 3.15% Compare
Median of peers $21.9B 28.2× 33.9× +8.30% +19.02% +32.16% 14.66% 3.53%

All 12 Healthcare Plans stocks →

Oscar Health, Inc. (OSCR) key facts

  • Strength: Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024.
  • Oscar Health, Inc. (OSCR) is a Healthcare Plans company in the Healthcare sector, listed on the New York Stock Exchange.
  • As of October 13, 2026, OSCR traded at $33.79, a market capitalization of $10.5 billion.
  • Return on equity was −44.4% and debt-to-equity 0.21.
  • Its Piotroski F-score is 3 out of 9 and its Altman Z-score is 1.07 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Oscar Health, Inc. (OSCR) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/OSCR · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com